Cerebrospinal fluid T cell clones from patients with multiple sclerosis: Recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells

European Journal of Immunology

Volumn 35, Issue 6, 2005, Pages 1786-1794

  Holmøy, Trygve ^a,b   Fredriksen, Agnete Brunsvik ^a,b   Thompson, Keith Michael ^a,b   Hestvik, Anne Lise Karlsgot ^a,b   Bogen, Bjarne ^a,b   Vartdal, Frode ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

CSF; Idiotopes; Multiple sclerosis; T cells

Indexed keywords

AMINO ACID; CD4 ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 5; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINO ACID SUBSTITUTION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CASE REPORT; CELL LINE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE MAPPING; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE CLONE; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; T LYMPHOCYTE;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPES; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 20844443544     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425417     Document Type: Article

References (69)

1. Oudin, J., The genetic control of immunoglobulin synthesis. Proc. R. Soc. Lond. B Biol. Sci. 1966. 166: 207-221.
2. Bogen, B., Jorgensen, T. and Hannestad, K., T helper cell recognition of idiotopes on lambda 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region. Eur. J. Immunol. 1985. 15: 278-281.
3. Eyerman, M. C., Zhang, X. and Wysocki, L. J., T cell recognition and tolerance of antibody diversity. J. Immunol. 1996. 157: 1037-1046.
4. Janeway, C. A., Jr., Sakato, N. and Eisen, H. N., Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes. Proc. Natl. Acad. Sci. USA 1975. 72: 2357-2360.
5. Jorgensen, T. and Hannestad, K., Specificity of T and B lymphocytes for myeloma protein 315. Eur. J. Immunol. 1977. 7: 426-431.
6. Jorgensen, T. and Hannestad, K., H-2-linked genes control immune response to V-domains of myeloma protein 315. Nature 1980. 288: 396-397.
7. Bogen, B., Malissen, B. and Haas, W., Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. Eur. J. Immunol. 1986. 16: 1373-1378.
8. Weiss, S. and Bogen, B., B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. USA 1989. 86: 282-286.
9. Bogen, B. and Weiss, S., B lymphoma cells process and present their endogenous IG: implications for network theory. Adv. Exp. Med. Biol. 1988. 237: 877-882.
10. Weiss, S. and Bogen, B., MHC class II-restricted presentation of intracellular antigen. Cell 1991. 64: 767-776.
11. Rudensky, A. Y. and Yurin, V. L., Immunoglobulin-specific T-B cell interaction. I. Presentation of self immunoglobulin determinants by B lymphocytes. Eur. J. Immunol. 1989. 19: 1677-1683.
12. + T cells in vivo. Eur. J. Immunol. 1999. 29: 4043-4052.
13. Bogen, B. and Weiss, S., Processing and presentation of idiotypes to MHC-restricted T cells. Int. Rev. Immunol. 1993. 10: 337-355.
14. Singh, R. R. and Hahn, B. H., Reciprocal T-B determinant spreading develops spontaneously in murine lupus: implications for pathogenesis. Immunol. Rev. 1998. 164: 201-208.
15. Zhang, X., Smith, D. S., Guth, A. and Wysocki, L. J., A receptor presentation hypothesis for T cell help that recruits autoreactive B cells. J. Immunol. 2001. 166: 1562-1571.
16. Munthe, L. A., Os, A., Zangani, M. and Bogen, B., MHC-Restricted Ig V Region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production. J. Immunol. 2004. 172: 7476-7484.
17. + T cells reactive to an immunoglobulin variable region. J. Exp. Med. 2004. 200: 1-11.
18. Ebling, F. M., Tsao, B. P., Singh, R. R., Sercarz, E. and Hahn, B. H., A peptide derived from an autoantibody can stimulate T cells in the (NZB × NZW)F1 mouse model of systemic lupus erythematosus. Arthritis Rheum. 1993. 36: 355-364.
19. Singh, R. R., Kumar, V., Ebling, F. M., Southwood, S., Sette, A., Sercarz, E. E. and Hahn, B. H., T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 1995. 181: 2017-2027.
20. Singh, R. R. and Hahn, B. H., Reciprocal T-B determinant spreading develops spontaneously in murine lupus: implications for pathogenesis. Immunol. Rev. 1998. 164: 201-208.
21. Singh, R. R., Hahn, B. H., Tsao, B. P. and Ebling, F. M., Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus. J. Clin. Invest. 1998. 102: 1841-1849.
22. Mendlovic, S., Brocke, S., Shoenfeld, Y., Ben Bassat, M., Meshorer, A., Bakimer, R. and Mozes, E., induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc. Natl. Acad. Sci. USA 1988. 85: 2260-2264.
23. Waisman, A., Mendlovic, S., Ruiz, P. J., Zinger, H., Meshorer, A. and Mozes, E., The role of the 16/6 idiotype network in the induction and manifestations of systemic lupus erythematosus. Int. Immunol. 1993. 5: 1293-1300.
24. Singh, R. R., Ebling, F. M., Sercarz, E. E. and Hahn, B. H., Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus. J. Clin. Invest. 1995. 96: 2990-2996.
25. Waisman, A., Ruiz, P. J., Israeli, E., Eilat, E., Konen-Waisman, S., Zinger, H., Dayan, M. and Mozes, E., Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. Proc. Natl. Acad. Sci. USA 1997. 94: 4620-4625.
26. Eilat, E., Dayan, M., Zinger, H. and Mozes, E., The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 2001. 98: 1148-1153.
27. Brosh, N., Zinger, H. and Mozes, E., Treatment of induced murine SLE with a peptide based on the CDR3 of an anti-DNA antibody reverses the pattern of pathogenic cytokines. Autoimmunity 2002. 35: 211-219.
28. van Schooten, W. C., Devereux, D., Ho, C. H., Quan, J., Aguilar, B. A. and Rust, C. J., Joint-derived T cells in rheumatoid arthritis react with self-immunoglobulin heavy chains or immunoglobulin-binding proteins that copurify with immunoglobulin. Eur. J. Immunol. 1994. 24: 93-98.
29. Isenberg, D. A., Shoenfeld, Y., Madaio, M. P., Rauch, J., Reichlin, M., Stollar, B. D. and Schwartz, R. S., Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet 1984. 2: 417-422.
30. Mendlovic, S., Shoenfeld, Y., Bakimer, R., Segal, R., Dayan, M. and Mozes, E., In vitro T cell functions specific to an anti-DNA idiotype and serological markers in patients with systemic lupus erythematosus (SLE). J. Clin. Immunol. 1988. 8: 178-187.
31. Williams, W. M., Staines, N. A., Muller, S. and Isenberg, D. A., Human T cell responses to autoantibody variable region peptides. Lupus 1995. 4: 464-471.
32. Dayan, M., Segal, R., Sthoeger, Z., Waisman, A., Brosh, N., Elkayam, O., Eilat, E., Fridkin, M. and Mozes, E., Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. J. Clin. Immunol. 2000. 20: 187-194.
33. Sandberg-Wollheim, M., Immunoglobulin synthesis in vitro by cerebrospinal fluid cells in patients with multiple sclerosis. Scand. J. Immunol. 1974. 3: 717-730.
34. Laterre, E. C., The gamma globulins of the cerebrospinal fluid in multiple sclerosis. Acta Neurol. Psychiatr. Belg. 1966. 66: 305-318.
35. Jin, Y. P., Pedro-Cuesta, J., Huang, Y. H. and Soderstrom, M., Predicting multiple sclerosis at optic neuritis onset. Mult. Scler. 2003. 9: 135-141.
36. Haghighi, S., Andersen, O., Rosengren, L., Bergstrom, T., Wahlstrom, J. and Nilsson, S., Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls. J. Neurol. 2000. 247: 616-622.
37. Colombo, M., Dono, M., Gazzola, P., Chiorazzi, N., Mancardi, G. and Ferrarini, M., Maintenance of B lymphocyte-related clones in the cerebrospinal fluid of multiple sclerosis patients. Eur. J. Immunol. 2003. 33: 3433-3438.
38. Qin, Y., Duquette, P., Zhang, Y., Olek, M., Da, R. R., Richardson, J., Antel, J. P., Talbot, P., Cashman, N. R., Tourtellotte, W. W., Wekerle, H. and Van Den, N. S., Intrathecal B cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab. Invest. 2003. 83: 1081-1088.
39. Qin, Y., Duquette, P., Zhang, Y., Talbot, P., Poole, R. and Antel, J., Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J. Clin. Invest 1998. 102: 1045-1050.
40. Owens, G. P., Kraus, H., Burgoon, M. P., Smith-Jensen, T., Devlin, M. E. and Gilden, D. H., Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann. Neurol. 1998. 43: 236-243.
41. Smith-Jensen, T., Burgoon, M. P., Anthony, J., Kraus, H., Gilden, D. H. and Owens, G. P., Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology 2000. 54: 1227-1232.
42. Baranzini, S. E., Jeong, M. C., Butunoi, C., Murray, R. S., Bernard, C. C. and Oksenberg, J. R., B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol. 1999. 163: 5133-5144.
43. Vartdal, F. and Vandvik, B., Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies. Clin. Exp. Immunol. 1983. 54: 641-647.
44. Holmøy, T., Vandvik, B and Vartdal, F., T cells from multiple sclerosis patients recognize immunoglobulin G from autologous cerebrospinal fluid. Mult. Scler. 2003. 3:228-34.
45. Cepok, S., Jacobsen, M., Schock, S., Omer, B., Jaekel, S., Boddeker, I., Oertel, W. H., Sommer, N. and Hemmer, B., Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 2001. 124: 2169-2176.
46. Yarchoan, R., Tosato, G., Blaese, R. M., Simon, R. M. and Nelson, D. L., Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells. J. Exp. Med. 1983. 157: 1-14.
47. Sutkowski, N., Conrad, B., Thorley-Lawson, D. A. and Huber, B. T., Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001. 15: 579-589.
48. Melcangi, R. C., Cavarretta, I., Magnaghi, V., Ciusani, E. and Salmaggi, A., Corticosteroids protect oligodendrocytes from cytokine-induced cell death. Neuroreport 2000. 11: 3969-3972.
49. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group,TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999. 53: 457-465.
50. Sthoeger, Z. M., Dayan, M., Tcherniack, A., Green, L., Toledo, S., Segal, R., Elkayam, O. and Mozes, E., Modulation of autoreactive responses of peripheral blood lymphocytes of patients with systemic lupus erythematosus by peptides based on human and murine anti-DNA autoantibodies. Clin. Exp. Immunol. 2003. 131: 385-392.
51. Reitan, S. K. and Hannestad, K., A syngeneic idiotype is immunogenic when borne by IgM but tolerogenic when joined to IgG. Eur. J. Immunol. 1995. 25: 1601-1608.
52. Lang, A. K., Macht, L. M., Kirwan, J. R., Wraith, D. C. and Elson, C. J., Ability of T cells from patients with rheumatoid arthritis to respond to immunoglobulin G. Immunology 1999. 98: 116-122.
53. Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P. and Amigorena, S., Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 1999. 189: 371-380.
54. Lanzavecchia, A., Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu. Rev. Immunol. 1990. 8: 773-793.
55. Bartnes, K. and Hannestad, K., Native IgG2a(b) is barely antigenic to major histocompatibility complex class II-restricted T cells owing to inefficient internalization by professional antigen-presenting cells. Immunology 2000. 99: 510-522.
56. Coyle, P. K., Detection and isolation of immune complexes in multiple sclerosis cerebrospinal fluid. J. Neuroimmunol. 1987. 15: 97-107.
57. Ulvestad, E., Williams, K., Vedeler, C., Antel, J., Nyland, H., Mork, S. and Matre, R., Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J. Neurol. Sci. 1994. 121: 125-131.
58. Rudensky, A. Y., Preston-Hurlburt, P., al Ramadi, B. K., Rothbard, J. and Janeway, C. A., Jr., Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 1992. 359: 429-431.
59. Snyder, C. M., Zhang, X. and Wysocki, L. J., Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells. J. Immunol. 2002. 168: 3865-3873.
60. Bogen, B., Snodgrass, R., Briand, J. P. and Hannestad, K., Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region. Eur. J. Immunol. 1986. 16: 1379-1384.
61. Hannestad, K., Kristoffersen, G. and Briand, J. P., The T lymphocyte response to syngeneic lambda 2 light chain idiotopes. Significance of individual amino acids revealed by variant lambda 2 chains and idiotopemimicking chemically synthesized peptides. Eur. J. Immunol. 1986. 16: 889-893.
62. Eyerman, M. C. and Wysocki, L., T cell recognition of somatically-generated Ab diversity. J. Immunol. 1994. 152: 1569-1577.
63. Reitan, S. K. and Hannestad, K., The primary IgM antibody repertoire: a source of potent idiotype immunogens. Eur. J. Immunol. 2001. 31: 2143-2153.
64. Thompson, K. M., Hough, D. W., Maddison, P. J., Melamed, M. D. and Hughes-Jones, N., The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8. 653 as a fusion partner. J. Immunol. Methods 1986. 94: 7-12.
65. Rosenqvist, E., Jossang, T. and Feder, J., Thermal properties of human IgG. Mol. Immunol. 1987. 24: 495-501.
66. Ruiz, M., Giudicelli, V., Ginestoux, C., Stoehr, P., Robinson, J., Bodmer, J., Marsh, S. G., Bontrop, R., Lemaitre, M., Lefranc, G., Chaume, D. and Lefranc, M. P., IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 2000. 28: 219-221.
67. Fitch, F. W. and Gajewski, T. F., In vitro assays for mouse lymphocyte function. In Current Protocols in Immunology, Suppl 24. Wiley, New York 1997, pp 3.13.1-3.13.4.
68. Gaudernack, G. and Lundin, K. E., Rapid immunomagnetic phenotyping of cells. J. Immunogenet. 1989. 16: 169-175.
69. Fazekas de St. Groth, S., The evaluation of limiting dilution assays. J. Immunol. Methods 1982. 49: R11-R23.